Email Updates

Search form

You are here

AVAC in the News

  • A new report has revealed how research and development for AIDS vaccines, microbicides, pre-exposure prophylaxis using antiretroviral drugs (PrEP) and treatment as prevention (TasP) are in danger of being slowed or even sidelined because of inadequate funding.

    October 26, 2016
    The Herald
  • The need for PrEP to be used in conjunction with condoms was highlighted when scientists announced that a second man taking the daily HIV-prevention pill had contracted a rare, drug-resistant strain of the virus.

    October 20, 2016
    Attitude
  • An aggressive program of voluntary male circumcision in Kenya—a procedure shown to reduce the risk of acquiring HIV—has already prevented thousands of infections, a researcher said here.

    October 20, 2016
    MedPage Today
  • This is the second case of a man on Truvada, the once-a-day pill that’s highly effective at preventing HIV, contracting a rare drug-resistant strain of the virus.

    October 19, 2016
    Buzz Feed
  • The next generation of biomedical HIV prevention will be a hot topic here at HIV Research for Prevention (HIVR4P) 2016. Long-acting novel antiretrovirals delivered through shots or implants, vaginal rings loaded with antiretrovirals and hormonal contraception, infusions of antibodies against HIV and new HIV vaccines are all on the table—and in the works.

    October 12, 2016
    MedScape
  • "Vaccine developers will insert pieces of HIV in the vaccine candidate. You can't become infected from the vaccine. They insert snippets that will help the body react to the virus," explained Mitchell Warren, the executive director of AVAC, a New York City-based NGO that advocates for the accelerated ethical development of HIV vaccine and prevention options.

    October 3, 2016
    The Body
  • Clinical trials for an HIV cure need a comprehensive, transparent engagement plan that includes educating all possible stakeholders, said Jessica Salzwedel of AVAC during a recent Stakeholder Engagement webinar based on the CUREiculum, a set of tools developed by a number of HIV organizations that provide information on HIV cure research.

    September 21, 2016
    TheBody.com
  • The panel called for responsible media reporting about the HIV cure research and advised that all articles about HIV cure research results should include perspectives and quotes from independent scientists not involved in the study or studies being reported, be skeptical about any articles making claims about timelines, always cite the original science paper, avoid inflating research results and avoid speaking about “HIV cure” by itself—always include the word “research”.

    July 29, 2016
    New Vision
  • Last year, South Africa’s Medicines Control Council approved PrEP and in June this year the government began rolling it out among selected sex worker programs around the country. There are hopes it will be rolled out in the public sector by the end of the year.

    July 22, 2016
    Devex
  • “When we say 'Black Lives Matter,'” said Michael Ighodaro, “Where are 'Black Gay Lives' in that?” A young, gay Nigerian refugee living with HIV in New York City, Ighodaro posed this question during a talk leading up to the International AIDS Conference (AIDS 2016).

    July 22, 2016
    Charleston Chronicle

Pages